Evidence map›Paper›PMID 40121196›Full record

ArticleNature communications2025

On-demand treatment of metabolic diseases by a synthetic drug-inducible exocytosis system.

Yaqing Si, Minghui He, Yilin Li, Jian Jiang, Yuxuan Fan, Shuai Xue, Xinyuan Qiu, Mingqi Xie

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yaqing Si *School of Basic Medical Sciences, Fudan University, Shanghai, China.ORCID http://orcid.org/0000-0001-7622-1908
Minghui He *School of Basic Medical Sciences, Fudan University, Shanghai, China.ORCID http://orcid.org/0000-0002-9634-7724
Yilin Li *Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China.ORCID http://orcid.org/0000-0001-6986-3232
Jian JiangWestlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China.ORCID http://orcid.org/0000-0002-1922-7489
Yuxuan FanWestlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China.ORCID http://orcid.org/0000-0002-5665-5669
Shuai XueWestlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China.ORCID http://orcid.org/0000-0002-2521-3833
Xinyuan QiuDepartment of Biology and Chemistry, College of Science, National University of Defense Technology, Changsha, Hunan, China.ORCID http://orcid.org/0000-0002-9662-8075
Mingqi XieWestlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China. xiemingqi@westlake.edu.cn.ORCID http://orcid.org/0000-0001-5657-532X

Funding

Ministry of Science and Technology of the People's Republic of China (Chinese Ministry of Science and Technology) 2020YFA0909200National Natural Science Foundation of China (National Science Foundation of China) 32071429
6 · The paper itself

Abstract

Here, we present StimExo as a rational design strategy allowing various user-defined control signals to trigger calcium-dependent exocytosis and mediate on-demand protein secretion in cell-therapy settings. Using a modular framework incorporating inducible protein-protein interactions into an engineered bipartite activator of calcium release-activated calcium (CRAC) channels, Ca

Indexed as

ExocytosisMetabolic DiseasesAnimalsBlood GlucoseCalciumDiabetes Mellitus, ExperimentalHEK293 CellsHumansInsulinMaleMiceORAI1 ProteinBlood GlucoseCalciumInsulinORAI1 Protein

Identifiers

PMID40121196
PMCPMC11929842

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.